15 Jun Notice of rescheduled AGM
AGM to be held in Paris on Thursday 10 August Paris, France and Eastleigh, UK – 15 June 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical...
12 Jun Reminder to shareholders re. AGM voting
Paris, France and Eastleigh, UK – 12 June 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, will be holding its annual general meeting (AGM) exclusively...
26 May Publication of Annual Report and AGM voting
Paris, France and Eastleigh, UK – 26 May 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual Report and Accounts...
10 May Notice of Annual General Meeting
Paris, France and Eastleigh, UK – 10 May 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting...
27 Apr Full year 2022 results
Full year revenue and EBITDA in line with guidance Accelerating product development post-COVID-19 to become a leading global clinical diagnostic company in infectious diseases Paris, France and Eastleigh, UK 27 April 2023...
17 Apr Notice of Full Year 2022 Results and Investor Presentation
Paris, France and Eastleigh, UK – 17 April 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it will report its audited...
30 Jan DHSC Claim update – Trial date listed
Posted at 08:00h
in Uncategorized
Paris, France and Eastleigh, UK – 30 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the High Court has notified Novacyt...
26 Jan Full Year 2022 Trading Update
Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases Paris, France and Eastleigh, UK –...
06 Jan Holdings in Company
Posted at 09:59h
in Uncategorized
Paris, France and Camberley, UK – 6 January 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified by Biosynex...
07 Dec Non-Executive Director Change
Paris, France and Eastleigh, UK – 7 Dec 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that Edwin Snape has informed the Board...